BEAM logo

Beam Therapeutics Inc.

BEAM
Healthcare|Biotechnology|US
$26.41
+0.54 (+2.09%)
Tangible Book / Share
$9.10
Cash / Share
$9.97

Ownership Breakdown

85.3%
Float
103.3M
Shares Outstanding
88.1M
Float Shares

Major Holders (31)

Combined: 258.8%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Abigail P. JohnsonIndividual12.60%12,750,369Feb 5, 202613D/G
FMR LLCHolding company12.60%12,750,369Feb 5, 202613D/G
Gehani, Varun N.HC, IN9.99%10,282,210Aug 13, 202613D/G
Dunn Hannah E.HC, IN9.99%10,282,210Aug 13, 202613D/G
Dreyfuss, Philip D.HC, IN9.99%10,282,210Aug 13, 202613D/G
Kim, David T.HC, IN9.99%10,282,210Aug 13, 202613D/G
Giauque, NicolasHC, IN9.99%10,282,210Aug 13, 202613D/G
Farallon Capital Management, L.L.C.IA, OO9.99%10,282,210Aug 13, 202613D/G
Linn, Michael G.HC, IN9.99%10,282,210Aug 13, 202613D/G
Husen, Avner A.HC, IN9.99%10,282,210Aug 13, 202613D/G
Dapice Joshua J.HC, IN9.99%10,282,210Aug 13, 202613D/G
Wehrly, Mark C.HC, IN9.99%10,282,210Aug 13, 202613D/G
Warren, John R.HC, IN9.99%10,282,210Aug 13, 202613D/G
Spokes, Andrew J. M.HC, IN9.99%10,282,210Aug 13, 202613D/G
Short Daniel S.HC, IN9.99%10,282,210Aug 13, 202613D/G
Saito Edric C.HC, IN9.99%10,282,210Aug 13, 202613D/G
Roberts, Jr., Thomas G.HC, IN9.99%10,282,210Aug 13, 202613D/G
Luo Patrick (Cheng)HC, IN9.99%10,282,210Aug 13, 202613D/G
Catherine D. WoodHC, IN9.95%10,234,862Aug 14, 202613D/G
ARK Investment Management LLCInvestment adviser9.95%10,234,862Aug 14, 202613D/G
BlackRock, Inc.Holding company7.50%7,499,930Apr 17, 202513D/G
State Street CorporationHolding company5.20%5,228,529Feb 9, 202613D/G
Vanguard Capital ManagementInvestment adviser5.02%5,122,475Apr 29, 202613D/G
Robert NelsenIndividual4.60%4,600,747May 15, 202513D/G
Clinton BybeeIndividual4.50%4,550,630May 15, 202513D/G
Keith CrandellIndividual4.50%4,557,862May 15, 202513D/G
ARCH Venture Partners IX, LLCOther4.50%4,540,132May 15, 202513D/G
ARCH Venture Partners IX Overage, L.P.Partnership4.50%4,540,132May 15, 202513D/G
ARCH Venture Partners IX, L.P.Partnership4.50%4,540,132May 15, 202513D/G
ARCH Venture Fund IX Overage, L.P.Partnership4.50%4,540,132May 15, 202513D/G
ARCH Venture Fund IX, L.P.Partnership4.50%4,540,132May 15, 202513D/G

Insider Trades (100)

Last 4 quarters: 1,052,060 acquired · 1,018,017 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Evans John M.director, officer: CEOOct 16, 2026OPTION EX.25,000$1.03$25.8KForm 4
Evans John M.director, officer: CEOOct 15, 2026SELL25,000$23.57$589.1KForm 4
Evans John M.director, officer: CEOOct 16, 2026SELL25,000$23.98$599.6KForm 4
Evans John M.director, officer: CEOOct 15, 2026OPTION EX.25,000$1.03$25.8KForm 4
Evans John M.director, officer: CEOOct 16, 2026OPTION EX.25,000$1.03$25.8KForm 4
Cavanagh Bethany JSVP, Finance and TreasurerOct 1, 2026SELL187$24.41$4.6KForm 4
Ciaramella GiuseppePresidentSep 24, 2026GIFT123,407——Form 4
Simon AmyChief Medical OfficerJul 27, 2026SELL16,667$25.74$429.0KForm 4
Simon AmyChief Medical OfficerJun 30, 2026SELL373$34.73$13.0KForm 4
Evans John M.director, officer: CEOJun 30, 2026OPTION EX.25,000$1.03$25.8KForm 4
Evans John M.director, officer: CEOJun 29, 2026OPTION EX.18,663$0.67$12.5KForm 4
Evans John M.director, officer: CEOJun 29, 2026SELL13,421$35.13$471.5KForm 4
Evans John M.director, officer: CEOJun 30, 2026SELL23,100$34.26$791.5KForm 4
Evans John M.director, officer: CEOJun 29, 2026SELL11,579$35.91$415.8KForm 4
Evans John M.director, officer: CEOJun 30, 2026SELL1,900$34.84$66.2KForm 4
Evans John M.director, officer: CEOJun 29, 2026OPTION EX.6,337$1.03$6.5KForm 4
Evans John M.director, officer: CEOJun 30, 2026OPTION EX.25,000$1.03$25.8KForm 4
Evans John M.director, officer: CEOJun 29, 2026OPTION EX.18,663$0.67$12.5KForm 4
FMR LLC10 percent owner, other: See Remark 1Jun 25, 2026SELL33,372$35.12$1.2MForm 4
FMR LLC10 percent owner, other: See Remark 1Jun 26, 2026SELL251,488$35.26$8.9MForm 4
Ciaramella GiuseppePresidentJun 17, 2026OPTION EX.29,000$1.03$29.9KForm 4
Ciaramella GiuseppePresidentJun 17, 2026OPTION EX.6,505$0.67$4.4KForm 4
Ciaramella GiuseppePresidentJun 17, 2026OPTION EX.29,000$1.03$29.9KForm 4
Ciaramella GiuseppePresidentJun 17, 2026OPTION EX.6,505$0.67$4.4KForm 4
Shaw ChristidirectorJun 3, 2026AWARD19,676$29.55$581.4KForm 4
Walsh Kathleen EdirectorJun 3, 2026AWARD19,676$29.55$581.4KForm 4
MARAGANORE JOHNdirectorJun 3, 2026AWARD19,676$29.55$581.4KForm 4
Fishman MarkdirectorJun 3, 2026AWARD19,676$29.55$581.4KForm 4
Guindo ChirfidirectorJun 3, 2026AWARD19,676$29.55$581.4KForm 4
COOPER GRAHAM KdirectorJun 3, 2026AWARD19,676$29.55$581.4KForm 4
Evans John M.director, officer: CEOApr 1, 2026SELL30,078$24.58$739.3KForm 4
Simon AmyChief Medical OfficerApr 1, 2026SELL6,700$24.58$164.7KForm 4
Cavanagh Bethany JSVP, Finance and TreasurerApr 1, 2026SELL3,242$24.58$79.7KForm 4
Bellon ChristineChief Legal OfficerApr 1, 2026SELL5,956$24.58$146.4KForm 4
Ciaramella GiuseppePresidentApr 1, 2026SELL11,810$24.58$290.3KForm 4
Bellon ChristineChief Legal OfficerMar 31, 2026AWARD20,000——Form 4
Cavanagh Bethany JSVP, Finance and TreasurerMar 31, 2026AWARD20,000——Form 4
Simon AmyChief Medical OfficerMar 31, 2026AWARD31,750——Form 4
Emany Sravan KumarChief Financial OfficerMar 31, 2026AWARD31,750——Form 4
Ciaramella GiuseppePresidentMar 31, 2026AWARD40,000——Form 4
Evans John M.director, officer: CEOMar 31, 2026AWARD90,000——Form 4
Evans John M.director, officer: CEOMar 31, 2026OPTION EX.25,000$0.67$16.8KForm 4
Evans John M.director, officer: CEOMar 30, 2026SELL25,000$22.37$559.2KForm 4
Evans John M.director, officer: CEOMar 31, 2026SELL25,000$22.76$569.1KForm 4
Evans John M.director, officer: CEOMar 30, 2026OPTION EX.25,000$0.67$16.8KForm 4
Evans John M.director, officer: CEOMar 31, 2026OPTION EX.25,000$0.67$16.8KForm 4
Ciaramella GiuseppePresidentFeb 24, 2026OPTION EX.35,000$17.00$595.0KForm 4
Ciaramella GiuseppePresidentFeb 24, 2026OPTION EX.35,000$17.00$595.0KForm 4
Ciaramella GiuseppePresidentFeb 24, 2026SELL35,000$32.00$1.1MForm 4
Cavanagh Bethany JSVP, Finance and TreasurerJan 31, 2026AWARD40,000$27.62$1.1MForm 4
Ciaramella GiuseppePresidentJan 31, 2026AWARD80,000$27.62$2.2MForm 4
Emany Sravan KumarChief Financial OfficerJan 31, 2026AWARD63,500$27.62$1.8MForm 4
Bellon ChristineChief Legal OfficerJan 31, 2026AWARD40,000$27.62$1.1MForm 4
Evans John M.director, officer: CEOJan 30, 2026OPTION EX.25,000$0.67$16.8KForm 4
Evans John M.director, officer: CEOJan 29, 2026OPTION EX.19,336$0.67$13.0KForm 4
Evans John M.director, officer: CEOJan 29, 2026SELL16,333$29.19$476.8KForm 4
Evans John M.director, officer: CEOJan 30, 2026SELL22,094$28.27$624.7KForm 4
Evans John M.director, officer: CEOJan 29, 2026SELL8,667$29.74$257.8KForm 4
Evans John M.director, officer: CEOJan 30, 2026SELL2,906$29.00$84.3KForm 4
Evans John M.director, officer: CEOJan 31, 2026AWARD180,000$27.62$5.0MForm 4
Evans John M.director, officer: CEOJan 29, 2026OPTION EX.5,664$0.67$3.8KForm 4
Evans John M.director, officer: CEOJan 30, 2026OPTION EX.25,000$0.67$16.8KForm 4
Evans John M.director, officer: CEOJan 29, 2026OPTION EX.19,336$0.67$13.0KForm 4
Simon AmyChief Medical OfficerJan 31, 2026AWARD88,500$27.62$2.4MForm 4
Cavanagh Bethany JSVP, Finance and TreasurerJan 22, 2026SELL6,198$35.00$216.9KForm 4
Bellon ChristineChief Legal OfficerJan 22, 2026SELL1,371$34.00$46.6KForm 4
Cavanagh Bethany JSVP, Finance and TreasurerJan 20, 2026SELL3,034$30.12$91.4KForm 4
Bellon ChristineChief Legal OfficerJan 15, 2026SELL2,111$33.62$71.0KForm 4
Bellon ChristineChief Legal OfficerJan 15, 2026SELL15,959$34.72$554.1KForm 4
Bellon ChristineChief Legal OfficerJan 15, 2026SELL559$35.40$19.8KForm 4
Emany Sravan KumarChief Financial OfficerDec 31, 2025SELL6,294$27.10$170.6KForm 4
Bellon ChristineChief Legal OfficerDec 31, 2025SELL1,254$27.10$34.0KForm 4
Simon AmyChief Medical OfficerDec 31, 2025AWARD12,500——Form 4
FMR LLC10 percent owner, other: See Remark 1Oct 27, 2025SELL459$26.68$12.2KForm 4
FMR LLC10 percent owner, other: See Remark 1Oct 6, 2025GIFT1,232,434——Form 4
Cavanagh Bethany JSVP, Finance and TreasurerOct 1, 2025SELL467$24.53$11.5KForm 4
Bellon ChristineChief Legal OfficerOct 1, 2025SELL373$24.53$9.1KForm 4
Evans John M.director, officer: CEOOct 2, 2025OPTION EX.25,000$0.67$16.8KForm 4
Evans John M.director, officer: CEOOct 2, 2025SELL25,000$24.63$615.7KForm 4
Evans John M.director, officer: CEOOct 1, 2025SELL25,000$24.51$612.7KForm 4
Evans John M.director, officer: CEOOct 1, 2025OPTION EX.25,000$0.67$16.8KForm 4
Evans John M.director, officer: CEOOct 2, 2025OPTION EX.25,000$0.67$16.8KForm 4
FMR LLC10 percent owner, other: See Remark 1Jul 30, 2025SELL48,374$20.50$991.7KForm 4
Simon AmyChief Medical OfficerJul 1, 2025SELL374$16.94$6.3KForm 4
Simon AmyChief Medical OfficerJul 3, 2025SELL876$20.12$17.6KForm 4
Walsh Kathleen EdirectorJun 4, 2025AWARD33,662$17.15$577.3KForm 4
Fishman MarkdirectorJun 4, 2025AWARD33,662$17.15$577.3KForm 4
Shaw ChristidirectorJun 4, 2025AWARD33,662$17.15$577.3KForm 4
Ho CaroledirectorJun 4, 2025AWARD33,662$17.15$577.3KForm 4
MARAGANORE JOHNdirectorJun 4, 2025AWARD33,662$17.15$577.3KForm 4
COOPER GRAHAM KdirectorJun 4, 2025AWARD33,662$17.15$577.3KForm 4
Guindo ChirfidirectorJun 4, 2025AWARD33,662$17.15$577.3KForm 4
FMR LLC10 percent owner, other: See Remark 1Mar 31, 2025OTHER0——Form 4
FMR LLC10 percent owner, other: See Remark 1Mar 31, 2025OTHER0——Form 4
FMR LLC10 percent owner, other: See Remark 1Mar 31, 2025OTHER0——Form 4
Bellon ChristineChief Legal OfficerApr 1, 2025SELL5,674$18.35$104.1KForm 4
Evans John M.director, officer: CEOApr 1, 2025SELL30,663$18.35$562.7KForm 4
Ciaramella GiuseppePresidentApr 1, 2025SELL7,434$18.35$136.4KForm 4
Cavanagh Bethany JSVP, Finance and TreasurerApr 1, 2025SELL3,015$18.35$55.3KForm 4
Simon AmyChief Medical OfficerApr 1, 2025SELL9,566$18.35$175.5KForm 4